Your session is about to expire
← Back to Search
SSRI or cognitive behavioral therapy for Obsessive-Compulsive Disorder
Study Summary
This trial is looking at people with OCD who have participated in a global study investigating brain signatures of OCD, funded by the National Institutes of Mental Health. The trial will assess clinical, neurocognitive and neuroimaging data, and participants who are willing to receive evidence-based treatments for OCD will be treated and assessed for treatment response status periodically, with a final assessment after 1 year of naturalistic follow-up.
- Obsessive-Compulsive Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the upper limit of people participating in this medical trial?
"This particular medical trial is not actively recruiting patients. It was initially posted on October 10th 2018 and the listing was last updated November 1st 2022. If you are seeking alternative clinical trials, there are presently 114 different studies searching for OCD sufferers and 7 experiments that require participants to test this treatment."
Does this experiment have an age limit, and if so, does it extend beyond fifty years?
"To be eligible for this medical study, participants must fall under the age of 50 and exceed 18 years old."
Is this treatment a novel approach, or has it been studied before?
"Presently, there are 7 ongoing trials for this specific intervention with none in the third phase. Although Cape Town and New york have a large number of studies being conducted for it, 25 other medical centres around the world are involved as well."
Are there still opportunities for participants to join this clinical research?
"The medical trial in question is not actively seeking participants at this current time. The study was first posted on October 10th 2018 and the last update was November 1st 2022, but there are still 121 other studies enrolling patients right now."
Is this approach to treatment efficacious and innocuous for individuals?
"This treatment is approved for use, so the safety score assigned by our Power team was a 3."
Would I be able to join this clinical experiment?
"This clinical trial, which hopes to recruit 250 participants in total, requires that those wishing to participate have an OCD diagnosis and are within the 18-50 year old age bracket."
Share this study with friends
Copy Link
Messenger